当前位置: X-MOL 学术Catheter. Cardiovasc. Interv. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A prospective trial of a novel low-dose paclitaxel-coated balloon therapy in patients with restenosis in drug-eluting coronary stents Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-stent REstenosis 3A (ISAR-DESIRE 3A)
Catheterization & Cardiovascular Interventions ( IF 2.1 ) Pub Date : 2021-11-18 , DOI: 10.1002/ccd.30014
Sebastian Kufner 1 , Himanshu Rai 1, 2, 3 , Jens Wiebe 1 , Felix Altevogt 1 , Stylianos Pyxaras 4 , Michael Joner 1, 5 , Erion Xhepa 1 , Salvatore Cassese 1 , Roisin Colleran 1, 2, 3 , Heribert Schunkert 1, 5 , Bernhard Zrenner 4 , Adnan Kastrati 1, 5 , Robert A. Byrne 1, 2, 3 ,
Affiliation  

We investigated the clinical efficacy of a paclitaxel-coated balloon (PCB) with a novel matrix coating and reduced drug concentration in comparison with a widely used PCB with iopromide excipient.

中文翻译:

一项新的低剂量紫杉醇涂层球囊治疗药物洗脱冠状动脉支架再狭窄患者的前瞻性试验

我们研究了紫杉醇涂层球囊 (PCB) 与具有碘普罗胺赋形剂的广泛使用的 PCB 相比,具有新型基质涂层和降低药物浓度的临床疗效。
更新日期:2021-11-18
down
wechat
bug